Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Phase 3 Trial Investigating Impact of Intravenous Efgartigimod in Anti-Acetylcholine Receptor Antibody Negative Generalized Myasthenia Gravis

Improvement of Troublesome Dyskinesia in People with Parkinson’s Disease Treated with Foslevodopa/Foscarbidopa